4
Changes in Ownership
Axogen, Inc. Filed Acc 0001179110-20-001943
VP, Clinical&Translational Sc gave up 1,849 shares (to pay taxes)
- VP, Clinical&Translational Sc acquired 6,230 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DeVinney Erick Wayne VP, Clinical&Translational Sc | 2020-02-18 | Grant or award | +5,049 | 49,194 | D: show line 1 in the form | ||
| DeVinney Erick Wayne VP, Clinical&Translational Sc | 2020-02-18 | Shares withheld for taxes | −1,498 | $14.68 | $21,991 | 47,696 | D: show line 2 in the form |
| DeVinney Erick Wayne VP, Clinical&Translational Sc | 2020-02-18 | Grant or award | +1,181 | 48,877 | D: show line 3 in the form | ||
| DeVinney Erick Wayne VP, Clinical&Translational Sc | 2020-02-18 | Shares withheld for taxes | −351 | $14.68 | $5,153 | 48,526 | D: show line 4 in the form |
Loading xslF345X03/edgar.xml…